Systm Wealth Solutions LLC Novartis Ag Transaction History

Systm Wealth Solutions LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $61,003 - $70,756	-659 Reduced 14.88%	3,771 $402 Million
Q1 2024 Apr 26, 2024	SELL	$95.27 - $108.47 $139,665 - $159,017	-1,466 Reduced 24.86%	4,430 $436 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $68,187 - $75,038	-739 Reduced 11.14%	5,896 $595 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $309,009 - $342,934	-3,262 Reduced 32.96%	6,635 $676 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $11,102 - $12,589	-120 Reduced 1.2%	9,897 $999 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $75,228 - $87,241	-940 Reduced 8.58%	10,017 $922 Million
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $827,801 - $1.01 Million	10,957 New	10,957 $994 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Systm Wealth Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Systm Wealth Solutions LLC with notifications on news.